A multi-ingredient food supplement slows age-dependent decline of mobility and influences gene expression in C. elegans.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model (C. elegans laboratory study)
PubMed 42365207 · doi:10.1007/s10522-026-10463-8
What was done
Researchers evaluated the effects of two commercial multi-ingredient food supplements (V14™, containing 40+ ingredients including dihydronicotinamide mononucleotide, trans-resveratrol, taurine, pterostilbene, and bioflavonoids; and AG1®, containing 70+ ingredients with 5 probiotic strains) versus a solvent control in *Caenorhabditis elegans*. Mobility and movement speed over time were tracked using automated WormGazer™ imaging as a proxy for healthspan. Transcriptomic profiling was performed on V14™-treated worms to evaluate gene expression changes.
What was found
The abstract reports no numerical values, effect sizes, or confidence intervals. Directionally, worms exposed to V14™ maintained significantly greater movement and speed with advancing age compared to both the solvent control and AG1®-treated worms. Transcriptomic analysis of V14™-treated worms revealed modulation of gene expression pathways involved in metabolism and cellular stress responses.
Why it matters
This study provides comparative preclinical testing of widely marketed multi-ingredient nutritional formulations on functional healthspan markers and transcriptomic pathways in a standard model organism.
Limits
The study was conducted entirely in an invertebrate model (*C. elegans*), limiting direct translation to human pharmacokinetics, dosing, or aging biology. The abstract does not disclose sample sizes, quantitative metrics, effect sizes, or specific gene targets. Because V14™ contains over 40 distinct ingredients, the individual bioactive molecules or synergistic mechanisms driving the observed outcome cannot be identified.
Cited by
- contradicts AG1 NextGen is backed by four clinical trials.